About ChemoMetec

ChemoMetec specializes in the development, production, and sale of high-quality analytical equipment for cell counting within a broad range of areas – for example, cell-based therapy, cancer and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen, beer, and milk.

Latest Financial Results

News Releases

September 11, 2024
Annual Report 2023/24 - Strengthened commercial focus after challenging year
September 11, 2024
Guidance for the 2024/25 financial year
July 4, 2024
Major shareholder announcement – BlackRock, Inc.